Status:
COMPLETED
Serum IL-17 Correlated With Inflammatory Changes in Osteoarthritis and Rheumatoid Arthritis
Lead Sponsor:
Zagazig University
Conditions:
Rheumatoid Arthritis (RA) and Osteoarthritis (OA)
Eligibility:
All Genders
Brief Summary
The total number of the included subjects was 120 in 3 equal groups (RA, OA and control). All subject was subjected to serum IL17 level measurement. MSK US (of both wrists, MCPs, PIPs and DIPs) was do...
Eligibility Criteria
Inclusion
- A patient is considered having definite RA if he/she scores at least 6 points in the established classification system
- A patient is considered having Hand OA if he /she Hand pain, aching, or stiffness plus 3 or 4 of hard tissue enlargement of 2 or more of 10 selected joints or hard tissue enlargement of 2 or more DIP joints or fewer than 3 swollen MCP joints, or deformity of at least 1 of 10 selected joints which are are the second and third distal interphalangeal (DIP), the second and third proximal interphalangeal, and the first carpometacarpal joints of both hands
Exclusion
- Any subject with liver diseases, coronary artery diseases, kidney diseases or other inflammatory conditions was excluded from the study.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 29 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04474912
Start Date
July 1 2020
End Date
November 29 2020
Last Update
November 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig University Faculty of Medicine
Zagazig, Sharqia Province, Egypt, 44519